The Asia Pacific Liquid Runway Deicer market size was valued at USD 89.4 million in 2024 and is projected to reach USD 116.2 million by 2030, at a CAGR of 4.5% during the forecast period 2024-2030.
Liquid runway deicers are chemical formulations used to prevent or remove ice and snow accumulation on airport runways, taxiways, and aprons, ensuring safe aircraft operations in cold weather conditions.
The Asia Pacific liquid runway deicer market is experiencing moderate growth, driven by expanding air travel and increasing focus on aviation safety. China accounts for 35% of the market, followed by Japan at 25% and South Korea at 20%. In 2023, potassium acetate-based deicers dominated with a 60% market share, followed by propylene glycol-based products at 30%. The market saw an 8% increase in demand for environmentally friendly formulations with lower corrosion potential. Key players include Clariant AG (Switzerland) and Cryotech Deicing Technology (USA), collectively holding a 45% market share in the region. The industry is investing in advanced application technologies, with a 15% increase in adoption of precision spraying systems in 2023. Challenges include environmental concerns and regulatory pressures, leading to a 10% focus on developing bio-based deicer alternatives. The trend towards preventive deicing has driven a 12% growth in demand for anti-icing liquids. The market is benefiting from the expansion of airport infrastructure in emerging economies, with a 20% increase in new airport construction projects incorporating modern deicing facilities.
Report Includes
This report is an essential reference for who looks for detailed information on Asia Pacific Tranexamic Acid . The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors information. In addition to the data part, the report also provides overview of Tranexamic Acid , including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user’s requirements is also available.
This report aims to provide a comprehensive presentation of the Asia Pacific Tranexamic Acid , with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tranexamic Acid . This report contains market size and forecasts of Tranexamic Acid in Asia Pacific, including the following market information:
We surveyed the Tranexamic Acid manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
by Country
• China
• India
• Japan
• South Korea
• Australia
• Thailand
• Indonesia
by Products type:
• USP25
• BP2000
• Other
by Application:
• Trauma
• Craniocerebral Trauma
• Menorrhagia
• Postpartum Hemorrhage
• Surgery
• Other Treatment
• Whitening Cosmetics
key players include: (At least 8-10 companies included)
• CSL Limited
• Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
• JK Sucralose Inc.
• Yunnan Baiyao Group Co., Ltd.
• OlainFarm
• Hisun Pharmaceuticals
• Pfizer Asia Pacific Pte. Ltd.
• Wanbang Biopharmaceuticals
• Sun Pharmaceutical Industries Ltd.
• Torrent Pharmaceuticals Ltd.
Including or excluding key companies relevant to your analysis.
Competitor Analysis
The report also provides analysis of leading market participants including:
• Key companies Tranexamic Acid revenues in Asia Pacific market, 2019-2024 (Estimated), ($ millions)
• Key companies Tranexamic Acid revenues share in Asia Pacific market, 2023 (%)
• Key companies Tranexamic Acid sales in Asia Pacific market, 2019-2024 (Estimated),
• Key companies Tranexamic Acid sales share in Asia Pacific market, 2023 (%)
Key Points of this Report:
• The depth industry chain includes analysis value chain analysis, porter five forces model analysis and cost structure analysis
• The report covers Asia Pacific and country-wise market of Tranexamic Acid
• It describes present situation, historical background and future forecast
• Comprehensive data showing Tranexamic Acid capacities, production, consumption, trade statistics, and prices in the recent years are provided
• The report indicates a wealth of information on Tranexamic Acid manufacturers
• Tranexamic Acid forecast for next five years, including market volumes and prices is also provided
• Raw Material Supply and Downstream Consumer Information is also included
• Any other user’s requirements which is feasible for us
Reasons to Purchase this Report:
• Analyzing the outlook of the market with the recent trends and SWOT analysis
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
• Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
• Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
• Distribution Channel sales Analysis by Value
• Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• 1-year analyst support, along with the data support in excel format.
Asia Pacific Tranexamic Acid Market – View in Detailed Research Report
🔟 1. CSL Limited
Headquarters: Melbourne, Australia
Key Offering: Tranexamic Acid USP25, BP2000, Other
CSL Limited is a leading biopharmaceutical company with a strong footprint in the Asia Pacific region. The company supplies Tranexamic Acid for trauma and surgical applications, maintaining a robust distribution network across major hospitals and pharmacies.
Sustainability Initiatives:
- Reducing carbon footprint of production facilities
- Investing in renewable energy sources for manufacturing
- Collaborating with local health authorities to improve access to Tranexamic Acid
9️⃣ 2. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Headquarters: Shanghai, China
Key Offering: Tranexamic Acid for trauma and postpartum hemorrhage
Shanghai Fosun Pharmaceutical is a diversified pharmaceutical group with a significant presence in the Asia Pacific. The company focuses on high-quality Tranexamic Acid products and has expanded its production capacity to meet rising demand.
Sustainability Initiatives:
- Implementing green manufacturing practices
- Enhancing waste reduction and recycling programs
- Supporting community health initiatives
8️⃣ 3. JK Sucralose Inc.
Headquarters: Singapore
Key Offering: Tranexamic Acid for surgical and cosmetic applications
JK Sucralose Inc. specializes in advanced pharmaceutical ingredients, including Tranexamic Acid for various therapeutic uses. The company is known for its rigorous quality control and innovation in drug formulation.
Sustainability Initiatives:
- Adopting sustainable sourcing of raw materials
- Reducing water consumption in production
- Investing in research for bio-based alternatives
7️⃣ 4. Yunnan Baiyao Group Co., Ltd.
Headquarters: Kunming, China
Key Offering: Tranexamic Acid for trauma and menorrhagia
Yunnan Baiyao Group is a historic Chinese pharmaceutical company with a diversified product portfolio. The company has recently expanded its Tranexamic Acid line to cater to the growing demand for hemostatic agents.
Sustainability Initiatives:
- Promoting eco-friendly packaging solutions
- Supporting local community health programs
- Investing in green chemistry research
6️⃣ 5. OlainFarm
Headquarters: Lviv, Ukraine (Asia Pacific operations in Vietnam)
Key Offering: Tranexamic Acid for trauma and postoperative bleeding
OlainFarm is a leading European pharmaceutical manufacturer with a growing presence in the Asia Pacific. The company focuses on high-quality Tranexamic Acid for trauma and surgical applications.
Sustainability Initiatives:
- Reducing greenhouse gas emissions in manufacturing
- Enhancing waste management systems
- Supporting sustainable healthcare initiatives
5️⃣ 6. Hisun Pharmaceuticals
Headquarters: Guangzhou, China
Key Offering: Tranexamic Acid for trauma and other treatments
Hisun Pharmaceuticals is a fast-growing Chinese pharmaceutical company with a focus on hemostatic agents. The company has invested heavily in R&D to improve Tranexamic Acid formulations.
Sustainability Initiatives:
- Implementing energy-efficient manufacturing processes
- Promoting responsible sourcing of raw materials
- Supporting community health education
4️⃣ 7. Pfizer Asia Pacific Pte. Ltd.
Headquarters: Singapore
Key Offering: Tranexamic Acid for trauma and surgical applications
Pfizer’s Asia Pacific division is a major player in the region’s pharmaceutical market, providing high-quality Tranexamic Acid to hospitals and healthcare providers.
Sustainability Initiatives:
- Reducing carbon footprint across the supply chain
- Investing in renewable energy for facilities
- Supporting global health programs
3️⃣ 8. Wanbang Biopharmaceuticals
Headquarters: Beijing, China
Key Offering: Tranexamic Acid for trauma and postpartum hemorrhage
Wanbang Biopharmaceuticals is a leading Chinese biopharmaceutical company specializing in hemostatic drugs. The company has expanded its production capacity to meet the growing demand in the Asia Pacific region.
Sustainability Initiatives:
- Implementing green manufacturing practices
- Reducing waste and improving resource efficiency
- Supporting local health initiatives
2️⃣ 9. Sun Pharmaceutical Industries Ltd.
Headquarters: Mumbai, India
Key Offering: Tranexamic Acid for trauma and other treatments
Sun Pharmaceutical Industries is one of India’s largest generic pharmaceutical companies. The company offers a broad range of Tranexamic Acid products for various therapeutic indications.
Sustainability Initiatives:
- Reducing energy consumption in production
- Investing in renewable energy projects
- Supporting community health programs
1️⃣ 10. Torrent Pharmaceuticals Ltd.
Headquarters: Chennai, India
Key Offering: Tranexamic Acid for trauma, surgery and whitening cosmetics
Torrent Pharmaceuticals is a leading Indian pharmaceutical company with a strong presence in the Asia Pacific. The company focuses on high-quality Tranexamic Acid for trauma and surgical applications.
Sustainability Initiatives:
- Reducing carbon emissions across the supply chain
- Investing in renewable energy for manufacturing
- Supporting local health and education initiatives
Download FREE Sample Report CTA: Asia Pacific Tranexamic Acid Market – View in Detailed Research Report
Get Full Report CTA: Asia Pacific Tranexamic Acid Market – View in Detailed Research Report
🌍 Outlook: The Future of Asia Pacific Tranexamic Acid Market
The Asia Pacific Tranexamic Acid market is poised for steady growth, driven by increasing healthcare expenditure, expanding surgical procedures, and a growing focus on trauma care. The market is also benefiting from regulatory support for hemostatic agents and the expansion of healthcare infrastructure across emerging economies.
📈 Key Trends Shaping the Market:
- Rising demand for Tranexamic Acid in trauma and surgical applications
- Increasing focus on bio-based and environmentally friendly formulations
- Growth of digital health solutions for patient monitoring and drug distribution
- Strategic partnerships between pharmaceutical companies and healthcare providers
For a detailed analysis of market dynamics, competitive landscape, and future growth opportunities, download the full report.
📊 Future Trends (2026-2034)
- Projected CAGR of 6% for Tranexamic Acid in Asia Pacific from 2026 to 2034
- Expansion of production capacity in China, India, and Southeast Asia
- Increased adoption of precision dosing technologies
- Regulatory focus on safety and efficacy leading to higher market consolidation
- Emergence of new therapeutic indications for Tranexamic Acid
- Top 10 Companies in the Raised Floor Systems Market (2026): Market Leaders Powering Global Infrastructure - July 7, 2026
- Top 10 Companies in the Southeast Asia Amylase Market (2026): Market Leaders Powering Regional Growth - July 7, 2026
- Top 10 Companies in the Stainless Steel EP (Electropolished) Pipe Market (2026): Market Leaders Powering Global Clean Technology - July 7, 2026